APA (7th ed.) Citation

Nose, T., Funakoshi, Y., Suto, H., Nagatani, Y., Imamura, Y., Toyoda, M., . . . Minami, H. (2022). Transition of the PD‑1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re‑challenge. Molecular and clinical oncology, 16(5), 104. https://doi.org/10.3892/mco.2022.2537

Chicago Style (17th ed.) Citation

Nose, Taku, Yohei Funakoshi, Hirotaka Suto, Yoshiaki Nagatani, Yoshinori Imamura, Masanori Toyoda, Naomi Kiyota, and Hironobu Minami. "Transition of the PD‑1 Occupancy of Nivolumab on T Cells After Discontinuation and Response of Nivolumab Re‑challenge." Molecular and Clinical Oncology 16, no. 5 (2022): 104. https://doi.org/10.3892/mco.2022.2537.

MLA (9th ed.) Citation

Nose, Taku, et al. "Transition of the PD‑1 Occupancy of Nivolumab on T Cells After Discontinuation and Response of Nivolumab Re‑challenge." Molecular and Clinical Oncology, vol. 16, no. 5, 2022, p. 104, https://doi.org/10.3892/mco.2022.2537.